Advertisement

Neural Mechanisms in Asthma

  • P. J. Barnes
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 98)

Abstract

In the seventeenth century it was commonly held that asthma was a nervous disease. Sir John Floyer believed that an attack of asthma occured when “nerves are filled with windy spirits” (Floyer 1698). Hyde Salter, in his brilliant description of asthma more than 100 years ago, wrote that “in asthma, there is no peculiarity in the stimulus, the air breathed in is the same in the asthmatic and the non-asthmatic…nor, probably, is there any peculiarity in the irritability of bronchial muscle; the peculiarity is confined to the link that connects these two — the nervous system — and consists in its perverse sensibility, in its receiving and transmitting on to the muscle, as a stimulus to contraction, that of which it should take cognizance…it is clear that the vice in asthma consists not in the production of any special irritant but in the irritability of the part irritated” (Salter 1868). Thus, asthma was seen as a disease of excessive irritability of the airways produced by neural mechanisms. Later, immunological theories of asthma gained favour and there was an emphasis on inflammatory mediators and mast cells. More recently there has been a re-awakening of interest in neurogenic mechanisms in asthma, now that it is clear that there is a complex interaction between inflammation and neural control of airways.

Keywords

Muscarinic Receptor Airway Smooth Muscle Allergy Clin Immunol Human Airway Ipratropium Bromide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Advenier C, Naline E, Drapeau G, Regoli D (1987) Relative potencies of neurokinins in guinea-pig and human bronchus. Eur J Pharmacol 139: 133–137PubMedGoogle Scholar
  2. Alexander HL, Paddock R (1921) Bronchial asthma: response to pilocarpine and epinephrine. Arch Intern Med 27: 184–191Google Scholar
  3. Andersson RGG, Grundstrom N (1983) The excitatory non-cholinergic, non- adrenergic nervous system of the guinea-pig airways. Eur J Respir Dis 64: 141–157Google Scholar
  4. Andersson RGG, Fugner A, Lundgren BR, Muacevic G (1986) Inhibitory effects of elonidine on bronchospasm induced in guinea-pig by vagal stimulation or antigen challenge. Eur J Pharmacol 123: 181–185PubMedGoogle Scholar
  5. Barnes PJ (1986a) State of art. Neural control of human airways in health and disease. Am Rev Respir Dis 134: 1289–1314PubMedGoogle Scholar
  6. Barnes PJ (1986b) Endogenous catecholamines and asthma. J Allergy Clin Immunol 77: 791–795PubMedGoogle Scholar
  7. Barnes PJ (1986c) Non-adrenergic non-cholinergic neural control of human airways. Arch Int Pharmacodyn 280 [Suppl]: 208–228PubMedGoogle Scholar
  8. Barnes PJ (1986d) Airway inflammation and autonomic control. Eur J Respir Dis 69 [Suppl 147]: 80–87Google Scholar
  9. Barnes PJ (1986e) Asthma as an axon reflex. Lancet i: 242–245Google Scholar
  10. Barnes PJ (1987a) Airway neuropeptides and asthma. Trends Pharm Sci 8: 24–27Google Scholar
  11. Barnes PJ (1987b) Muscarinic receptors in lung. Postgrad Med J 63: [Suppl]: 13–19Google Scholar
  12. Barnes PJ (1987c) Neuropeptides in the lung: localization, function and pathophysiologic implications. J Allergy Clin Immunol 79: 285–295PubMedGoogle Scholar
  13. Barnes PJ. (1987d) Cholinergic control of airway smooth muscle. Am Rev Respir Dis 136: S42–45PubMedGoogle Scholar
  14. Barnes PJ (1987e) Neuropeptides in human airways: function and clinical implications. Am Rev Respir Dis 136: S77–83PubMedGoogle Scholar
  15. Barnes PJ (1988) Adrenergic regulation of airway function. In:Kaliner MA, Barnes PJ (eds) The airways: neural control in health and disease. Dekker, New York, pp 57–85Google Scholar
  16. Barnes PJ (1989) Muscarinic receptor subtypes: implications for lung disease. Thorax 44: 161–167PubMedGoogle Scholar
  17. Barnes PJ, Lundberg JM (1990) Airway neuropeptides and asthma. In: Kaliner M, Barnes PJ, Persson CGA (eds) Asthma and bronchial hyperresponsiveness: pathogenesis and treatment. Dekker, New York (in press)Google Scholar
  18. Barnes PJ, Dollery CT, MacDermot J (1980) Increased pulmonary a-adrenergic and reduced (3-adrenergic receptors in experimental asthma. Nature 285: 569–571PubMedGoogle Scholar
  19. Barnes PJ, Brown MJ, Silverman M, Dollery CT (1981a) Circulating catecholamines in exercise and hyperventilation-induced asthma. Thorax 36: 435–440PubMedGoogle Scholar
  20. Barnes PJ, Ind PW, Dollery CT (1981b) Inhaled prazosin in asthma. Thorax 36: 378–381PubMedGoogle Scholar
  21. Barnes PJ, Wilson NM, Vickers H (1981c) Prazosin, an alphal-adrenoceptor antagonist partially inhibits exercise-induced asthma. J Allergy Clin Immunol 68: 411–419PubMedGoogle Scholar
  22. Barnes PJ, Basbaum CB, Nadel JA, Roberts JM (1982a) Localization of P- adrenoceptors in mammalian lung by light microscopic autoradiography. Nature 299: 444–447.PubMedGoogle Scholar
  23. Barnes PJ, Ind PW, Brown MJ (1982b) Plasma histamine and catecholamines in stable asthmatic subjects. Clin Sci 62: 661–665PubMedGoogle Scholar
  24. Barnes PJ, Basbaum CB, Nadel JA (1983a) Autoradiographic localization of autonomic receptors in airway smooth muscle: marked differences between large and small airways. Am Rev Respir Dis 127: 758–762PubMedGoogle Scholar
  25. Barnes PJ, Skoogh B-E, Nadel JA, Roberts JM (1983b) Postsynaptic a2- adrenoceptors predominate over alphal-adrencoptors in canine tracheal smooth muscle and mediate neuronal and humoral alpha-adrenergic contraction. Mol Pharmacol 23: 570–575PubMedGoogle Scholar
  26. Barnes PJ, Skoogh B-E, Brown JK, Nadel J A (1983c) Activation of alpha-adrenergic responses in tracheal smooth muscle: a post-receptor mechanism. J Appl Physiol 54: 1469–1476PubMedGoogle Scholar
  27. Barnes PJ, Grandordy BM, Page CP, Rhoden KJ, Robertson DN (1987) The effect of platelet activating factor on pulmonary beta-adrenoceptors. Br J Pharmacol 90: 709–715PubMedGoogle Scholar
  28. Barnes PJ, Minette PA, Maclagan J (1988) Muscarinic receptor subtypes in lung. Trends Pharmacol Sci 9: 412–s416PubMedGoogle Scholar
  29. Baudouiri SV, Aitman TJ, Johnson AJ (1988) Prazosin in the treatment of chronic asthma. Thorax 43: 385–387Google Scholar
  30. Belvisi MG, Chung KF, Jackson DM, Barnes PJ (1988) Opioid modulation of non- colinergic neural bronchoconstriction in guinea-pig in vivo. Br J Pharmacol 95: 413–418PubMedGoogle Scholar
  31. Belvisi MG, Ichinose M, Barnes PJ (1989a) Evidence for GAB A B receptors on non-adrenergic non-cholinergic nerves in guinea-pig airways. Br J Pharmacol 97: 1225–1231PubMedGoogle Scholar
  32. Belvisi MG, Rogers DF, Barnes PJ (1989b) Neurogenic plasma extravasation:inhibition by morphine in guinea pig airways in vivo. J Appl Physiol 66: 268–272PubMedGoogle Scholar
  33. Blaber LC, Fryer AD, Maclagan J (1985) Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle. Br J Pharmacol 86: 723–728PubMedGoogle Scholar
  34. Bloom JW, Yamamura HI, Baumgartner C, Halonen M (1987) A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction. Eur J Pharmacol 133: 21–27PubMedGoogle Scholar
  35. Bloom JW, Baumgartener-Folkerts C, Palmer JD, Yamamura HI, Halonen M (1988) A muscarinic receptor subtype modulates vagally stimulated bronchial contraction. J Appl Physiol 85: 2144–2150Google Scholar
  36. Bonner TI, Buckley NJ, Young AC, Bann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527–532PubMedGoogle Scholar
  37. Bonner TI, Young AC, Brann MR, Buckley NJ (1988) Cloning and expression of the human and rat M5 muscarinic acetylcholine receptor genes. Neuron 1: 403–410PubMedGoogle Scholar
  38. Boschetto P, Roberts NM, Rogers DF, Barnes PJ (1989) Effect of anti-asthma drugs on microvascular leakage in guinea-pig airways. Am Rev Respir Dis 139: 416–421PubMedGoogle Scholar
  39. Boushey HA (1984) The role of the parasympathetic system in the regulation of bronchial smooth msucle. Eur J Respir Dis 65 [Suppl]: 80–90Google Scholar
  40. Boushey HA, Hotzman MJ, Sheller JR, Nadel JA (1980) Bronchial hyperreactivity. Am Rev Respir Dis 121: 389–413PubMedGoogle Scholar
  41. Brain SD, Williams TJ, Tippins JR, Morris HR, Maclntyre I (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313: 54–56PubMedGoogle Scholar
  42. Brown JK, Shields R, Jones C, Gold WM (1983) Augmentation of alpha-adrenergic responsiveness in trachealis muscle of living dogs. J Appl Physiol 54: 1558–1566PubMedGoogle Scholar
  43. Cadieux A, Springall DR, Mulderry PK, Rodrigo J, Ghatei MA, Terenghi G, Bloom SR, Polak JM (1986) Occurrence, distribution and ontogeny of CGRP- immunoreactivity in the rat lower respiratory tract: effect of capsaicin treatment and surgical denervations. Neuroscience 19: 605–627PubMedGoogle Scholar
  44. Carstairs JR, Nimm AJ, Barnes PJ (1985) Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 132: 541–547PubMedGoogle Scholar
  45. Caughey GH, Leidig F, Viro NF, Nadel JA (1988) Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 244: 133–137PubMedGoogle Scholar
  46. Cerrina J, Ladurie ML, Labat C, Raffestin B, Bayol A, Brink C (1986) Comparison of human bronchial muscle responses to histamine in vivo with histamine and isoprotenerol agonists in vitro. Am Rev Respir Dis 134: 57–61PubMedGoogle Scholar
  47. Chung KF, Evans TW, Graf PD, Nadel JA (1985) Modulation of cholinergic neurotransmission in canine airways by thromboxane-mimetic U 46619. Eur J Pharmacol 117: 373–375PubMedGoogle Scholar
  48. Coleridge JCG, Coleridge HM (1984) Afferent vagal C fibre innervation of the lung and airways and its functional significance. Rev Physiol Biochem Pharmacol 99: 1–110PubMedGoogle Scholar
  49. Coles SJ, Neill KH, Reid LM (1984) Potent stimulation of glycoprotein secretion in canine trachea by substance P. J Appl Physiol 57: 1323–1327PubMedGoogle Scholar
  50. Cryer PE (1980) Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 303: 436–444PubMedGoogle Scholar
  51. Danger AH J, van den Ende R, Lorenz RR, Flavahan NA, Vanhoutte PM (1987) Prejunctional betal-adrenoceptors inhibit cholinergic neurotransmission in canine bronchi. J Appl Physiol 62: 785–790Google Scholar
  52. Engels F, Oosting RS, Nijkamp FP (1985) Pulmonary macrophages induce deterioration of guinea-pig tracheal p-adrenergic function through release of oxygen radicals. Eur J Pharmacol 111: 143–144PubMedGoogle Scholar
  53. Evans TW, Dixon CMS, Clarke B, Conradson T-B, Barnes PJ (1988) Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol 25: 273–275PubMedGoogle Scholar
  54. Floyer J (1968) A treatise of the asthma. Wilkins, LondonGoogle Scholar
  55. Frossard N, Barnes PJ (1987) i-Opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways. Eur J Pharmacol 141: 519–522Google Scholar
  56. Frossard N, Rhoden KJ, Barnes PJ (1989) Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 248: 292–299PubMedGoogle Scholar
  57. Fryer AD, Maclagan J (1984) Muscarinic inhibitory receptors in pulmonary parasymathetic nerves in the guinea-pig. Br J Pharmacol 83: 973–978PubMedGoogle Scholar
  58. Fryer AD, Maclagan J (1987) Ipratropium bromide potentiates bronchoconstriction induced by vagal nerve stimulation in the guinea-pig. Eur J Pharmacol 139: 187–191PubMedGoogle Scholar
  59. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ (1987a) Bradykinin-induced bronchoconstriction in man: mode of action. Am Rev Respir Dis 135: 176–180PubMedGoogle Scholar
  60. Fuller RW, Maxwell DL, Dixon CMS, McGregor GP, Barnes VF, Bloom SR, Barnes PJ (1987b) The effects of substance P on cardiovascular and respiratory function in human subjects. J Appl Physiol 62: 1473–1479PubMedGoogle Scholar
  61. Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW (1986) In vitro responsiveness of human asthmatic blockers to carbachol, histamine, (3-receptor agonists and theophylline. Br J Clin Pharmacol 22: 669–676PubMedGoogle Scholar
  62. Grandordy BM, Barnes PJ (1987) Phosphoinositide turnover in airway smooth muscle. Am Rev Respir Dis 136 [Suppl]: S17–20PubMedGoogle Scholar
  63. Grandordy BM, Frossard N, Rhoden KJ, Barnes PJ (1988) Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction. Mol Pharmacol 33: 515–519PubMedGoogle Scholar
  64. Grandordy B, Rhoden K, Barnes PH (1990) Effects of protein kinase C activation on adrenoceptors in airway smooth muscle. Biochem Biophys Res Commun (in press)Google Scholar
  65. Gross NJ (1988) Ipratropium bromide. N Engl J Med 319: 486–494PubMedGoogle Scholar
  66. Gross NJ, Skorodin MS (1984a) Anticholinergic antimuscarinic bronchodilators. Am Rev Respir Dis 129: 856–870PubMedGoogle Scholar
  67. Gross NJ, Skorodin MS (1984b) Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 311: 321–325Google Scholar
  68. Grundstrom N, Andersson RGG, Wikberg JES (1981) Prejunctional alpha2- adrenoceptors inhibit contraction of tracheal smooth muscle by inhibitory cholinergic neurotransmission. Life Sci 28: 2981–2986PubMedGoogle Scholar
  69. Hall AK, Barnes PJ, Meldrum LA, Maclagan J (1989) Facilitation by tachykinins of neurotransmission in guinea-pig pulmonary parasympathetic nerves. Br J Pharmacol 97: 274–280PubMedGoogle Scholar
  70. Hall I, Chilvers ER (1989) Inositol phosphates and airway smooth muscle. Pulm Pharmacol 2: 113–120PubMedGoogle Scholar
  71. Ichinose M, Barnes PJ (1989) Inhibitory histamine H3-receptors on cholinergic nerves in human airways. Eur J Pharmacol 163: 383–386PubMedGoogle Scholar
  72. Ichinose M, Inoue H, Miura M, Takishima T (1988) Nonadrenergic bronchodilation in normal subjects. Am Rev Respir Dis 138: 31–34PubMedGoogle Scholar
  73. Ichinose M, Stretton CD, Schwartz J-C, Barnes PJ (1989) Histamine H3-receptors inhibit cholinergic neurotransmission in guinea pig airways. Br J Pharmacol 97: 13–15PubMedGoogle Scholar
  74. Ind PW, Brown MJ, Barnes PJ (1983) Sympathoadrenal responses in asthma. Thorax 38: 702Google Scholar
  75. Ind PW, Barnes PJ, Brown MJ, Dollery CT (1985a) Plasma histamine concentration during propranolol induced bronchoconstriction. Thorax 40: 903–909PubMedGoogle Scholar
  76. Ind PW, Causon RC, Brown MJ, Barnes PJ (1985b) Circulating catecholamines in acute asthma. Br Med J 290: 267–279Google Scholar
  77. Ind PW, Dixon CMS, Fuller RW, Barnes PJ (1989) Anticholinergic blockade of beta-blocker induced bronchoconstriction. Am Rev Respir Dis 139: 1390–1394PubMedGoogle Scholar
  78. Johnson AR, Asthon J, Schulz WW Erdos EG (1985) Neutral metalloendopeptidases in human lung tissue and cultured cells. Am Rev Respir Dis 132: 564–568Google Scholar
  79. Joos G, Pauwels R, van der Straeten M (1987) Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 42: 779–783Google Scholar
  80. Kaliner MA, Barnes PJ (eds) (1988) The airways: neural control in health and disease. Dekker, New York, pp 657 (Lung biology in health and disease series, vol 33 )Google Scholar
  81. Kaliner M, Shelhamer J, Davis PB, Smith LJ, Venter JC (1982) Autonomic nervous system abnormalities and allergy. Ann Intern Med 96: 349–357PubMedGoogle Scholar
  82. Kallenbach JM, Webster T, Dowdeswell R, Reinach SG, Scott Millar RN, Zwi S (1985) Reflex heart rate control in asthma. Chest 87: 644–648Google Scholar
  83. Kaufman MP, Coleridge HM, Coleridge JCG, Baker DG (1980) Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol 48: 551–517Google Scholar
  84. Kneussl MP, Richardson JB (1978) Alpha-adrenergic receptors in human and canine tracheal and bronchial smooth muscle. J Appl Physiol 45: 307–311PubMedGoogle Scholar
  85. Laitinen A, Partanen M, Hervonen A, Peto-Huikko M, Laitinen LA (1985) VIP-like immunoreactive nerves in human respiratory tract. Light and election micrso- scopic study. Histochemistry 82: 313–319PubMedGoogle Scholar
  86. Lammers J-W, Minette P, McCusker MT, Chung KF, Barnes PJ (1988) Nonad- renergic bronchodilator mechanisms in normal human subjects in vivo. J Appl Physiol 64: 1817–1822PubMedGoogle Scholar
  87. Lammers J-W, Minette P, McCusker M, Barnes PJ (1989a) The role of pirenzepine- sensitive (Ml) muscarinic receptors in vagally mediated bronchoconstriction in humans. Am Rev Respir Dis 139: 446–449PubMedGoogle Scholar
  88. Lammers J-W, Minette P, McCusker MT, Chung KF, Barnes PJ (1989b) Capsaicin; induced bronchodilation in asthmatic patients: role of the nonadrenergic inhibitory system. J Appl Physiol 67: 856–861PubMedGoogle Scholar
  89. Larssen K, Grunneberg R, Hjemdahl P (1985) Bronchodilatation and inhibition of allergen-induced bronchoconstriction by circulatory epinephrine in asthmatic subjects. J Allergy Clin Immunol 75: 586–593Google Scholar
  90. Larssen K, Martinsson A, Hjemdahl P (1986) Influence of circulating 4a-adrenoceptor agonists on pulmonary function and cardiovascular variables in patients with exercise induced asthma and healthy subjects. Thorax 41: 522–528Google Scholar
  91. Lundberg JM, Saria A (1987) Polylpeptide-containing neurons in airway smooth muscle. Ann Rev Physiol 49: 557–572Google Scholar
  92. Lundberg JM, Martling C-R, Saria A (1983a) Substance P and capsaicin-induced contraction of human bronchi. Acta Physipl Scand 119: 49–53Google Scholar
  93. Lundberg JM, Saria A, Brodin E, Rusells S, Folkers R (1983b) A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea-pig. Proc Natl Acad Sci USA 80: 1120–1124PubMedGoogle Scholar
  94. Lundberg JM, Saria A, Lundblad L, Angaard A, Martling C-R, Theodorsson- Norheim E, Stjarne P, Hokfelt T (1988) Bioactive peptides in capsaicin-sensitive C-fiber afferents of the airways: functional and pathophysiological implications. In: Kaliner MA, Barnes PJ (eds) The airways: neural control in health and disease. Dekker, New York, pp 417–445Google Scholar
  95. Mak JCM, Barnes PJ (1988) Autoradiographic localization of calcitonin gene-related peptide binding sites in human and guinea pig lung. Peptides 9: 957–964PubMedGoogle Scholar
  96. Mann JS, George CF (1985) Anticholinergic drugs in the treatment of airways disease. Br J Dis Chest 79: 209–228PubMedGoogle Scholar
  97. Martling C-R, Theordorsson-Norheim E, Lundberg JM (1987) Occurrence and effects of multiple tachykinins: substance P, neurokinin A, neuropeptide K in human lower airways. Life Sci 40: 1633–1643PubMedGoogle Scholar
  98. McCaig DJ (1987) Comparison of autonomic responses in the trachea isolated from normal and albumin sensitive guinea-pigs. Br J Pharmacol 92: 809–816PubMedGoogle Scholar
  99. McCormack DG, Salonen RO, Widdicombe JG, Barnes PJ (1988) Sensory neuropeptides are potent vasodilators of canine bronchial arteries in vitro. Am Rev Respir Dis 137 [Suppl]: 369Google Scholar
  100. Michoud M-C, Amyot R, Jeanneret-Grosjean A, Couture J (1987) Reflex decrease of histamine-induced bronchoconstriction after laryngeal stimulation in humans. Am Rev Respir Dis 136: 618–622PubMedGoogle Scholar
  101. Minette PA, Barnes PJ (1988) Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea-pig airways. J Appl Physiol 64: 2532–2537PubMedGoogle Scholar
  102. Minette PA, Barnes PJ (1989) Muscarinic receptor subtypes in airways: function and clinical significance. Am Rev Respir Dis 141: 8162–8165Google Scholar
  103. Minette PA, Lammers J-W, Barnes PJ (1988) Is there a defect in inhibitory muscarinic receptors in asthma? Am Rev Respir Dis 137: 239Google Scholar
  104. Mitchelson F (1988) Muscarinic receptor differentiation. Pharmacol Ther 37: 357–423PubMedGoogle Scholar
  105. Nadel JA (1980) Autonomic regulation of airway smooth muscle. In: Nadel JA (ed) Physiology and pharmacology of the airways. Dekker, New York, pp 217–257Google Scholar
  106. Nadel JA, Barnes PJ (1984) Autonomic regulation of the airways. Annu Rev Med 35: 451–467PubMedGoogle Scholar
  107. Nadel JA, Barnes PJ, Holtzman MJ (1986) Autonomic factors in the hyperreactivity of airway smooth muscle. In: Handbook of Physiology: the respiratory system, vol III. American Physiological Society, Besthesda, pp 693–702Google Scholar
  108. Nichol GM, Nix A, Chung KF, Barnes PJ (1989) Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic asthmatic and non-asthmatic subjects. Thorax 44: 1009–1014PubMedGoogle Scholar
  109. Nilsson G, Dahlberg K. Brodin E, Sundler F, Strandberg K (1977) Distribution and constrictor effect of substance P in guinea pig tracheobronchial tissue. In: von Euler US, Pernow B (eds) Substance P. Raven Press, New York, pp 57–61Google Scholar
  110. Ollerenshaw SL, Jarvis DL, Woolcock AJ, Scheibner T, Sullivan CE (1989a) Substance P immunoreactive nerve fibers in airways from patients with and without asthma. Am Rev Respir Dis 139: A237Google Scholar
  111. Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T (1989b) Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 320: 1244–1248PubMedGoogle Scholar
  112. Palmer JBD, Barnes PJ (1987) Neuropeptides and airway smooth muscle function. Am Rev Respir Dis 136: S50–54PubMedGoogle Scholar
  113. Palmer JB, Cuss FMC, Barnes PJ (1986) VIP and PHM and their role in non-adrenergic inhibitory responses in isolated human airways. J Appl Physiol 61: 1322–1328PubMedGoogle Scholar
  114. Postma DS, Keyzer JJ, Koeter GH, Sluiter HJ, De Vries K (1985) Influence of the parasympathetic and sympathetic nervous systems on nocturnal bronchial obstruction. Clin Sci 69: 251–258PubMedGoogle Scholar
  115. Rebuck AS, Chapman KR, Abboud R, Pare PD, Kreisman H, Wolkove N, Vickerson P (1987) Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 82: 59–64PubMedGoogle Scholar
  116. Rhoden KJ, Meldrum LA, Barnes PJ (1988) Inhibition of cholinergic neurotransmission in human airways by beta2-adrenoceptors. J Appl Physiol 65: 700–705PubMedGoogle Scholar
  117. Richardson JB (1979) State of art. Nerve supply to the lungs. Am Rev Respir Dis 119: 785–802PubMedGoogle Scholar
  118. Richardson J, Beland J (1976) Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol 41: 764–771PubMedGoogle Scholar
  119. Robertson DN, Rhoden KJ, Grandordy B, Page CP, Barnes PJ (1988) The effect of platelet activating factor on histamine and muscarinic receptor function in guinea-pig airways. Am Rev Respir Dis 137: 1317–1322PubMedGoogle Scholar
  120. Rogers DF, Barnes PJ (1989) Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet i: 930–932Google Scholar
  121. Rogers DF, Belvisi MG, Aursudkij B, Evans TW, Barnes PJ (1988a) Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea pig. Br J Pharmacol 95: 1109–1116PubMedGoogle Scholar
  122. Rogers DF, Aursudkij B, Barnes PJ (1989) Effects of tachykinins on mucus secretion in human bronchi in vitro. Eur J Pharmacol 174: 283–286PubMedGoogle Scholar
  123. Salone RO, Webber SE, Widdicombe JG (1988) Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo. Br J Pharmacol 95: 1262–1270Google Scholar
  124. Salter HH (1868) On asthma: its pathology and treatment, 2nd edn. Churchill, LondonGoogle Scholar
  125. Sands MF, Douglas FL, Green J, Banner AS, Robertson GL, Leff AR (1985) Homeostatic regulation of bronchomotor tone by sympathetic activation during bronchoconstriction in normal and asthmatic humans. Am Rev Respir Dis 132: 993–998PubMedGoogle Scholar
  126. Saria A, Martling C-R, Yan Z, Theordorson-Norheim E, Gamse R, Lundberg JM (1988) Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethyulphenyl piperazinium and vagal nerve stimulation. Am Rev Respir Dis 137: 1330–1335PubMedGoogle Scholar
  127. Sekizawa K, Tamaoki J, Nadel JA, Borson DB (1987) Enkephalinase inhibitor potentiates substance P and electrically induced contraction in ferret trachea. J Appl Physiol 63: 1401–1405PubMedGoogle Scholar
  128. Sekizawa K, Caughey GH, Lazarus SK, Gold WM, Nadel JA (1989) Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J Clin Invest 83: 175–179PubMedGoogle Scholar
  129. Skidgel RA, Engelbrecht A, Johnson AR, Erdos EG (1984) Hydrolysis of substance P and neurokinins by converting enzyme and neutral endoproteinase. Peptides 5: 769–776PubMedGoogle Scholar
  130. Szentivanyi A (1968) The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42: 203–232Google Scholar
  131. Szolcsanyi J (1988) Antidromic vasodilatation and neurogenic inflammation. Agents Actions 23: 5–11Google Scholar
  132. Tan WC, Cripps E, Douglas N, Sudlow MF (1982) Protective effects of drugs on bronchoconstriction induced by sulphur dioxide. Thorax 37: 671–676PubMedGoogle Scholar
  133. Tanaka DT, Grustein MM (1986) Effect of substance P on neurally mediated contraction of rabbit airway smooth muscle. J Appl Physiol 60: 458–463PubMedGoogle Scholar
  134. Tattersfield AE, Holgate ST, Harvey JE, Gribbin HR (1983) Is asthma due to partial beta-blockade of airways. Agents Actions 13: 265–271Google Scholar
  135. Thompson JE, Scypinski LA, Gordon T, Sheppard D (1987) Tachykinins mediate the increase in airway responsiveness caused by toluene diisocynante. Am Rev Respir Dis 136: 43–49PubMedGoogle Scholar
  136. Thomson NC (1987) In vivo versus in vitro human airway responsiveness to different pharmacologic stimuli. Am Rev Respir Dis 136: S58–62PubMedGoogle Scholar
  137. Uddman R, Luts A, Sundler F (1985) Occurrence and distribution of calcitonin gene-related peptide in the mammalian respiratory tract and middle ear. Cell Tissue Res 241: 551–555PubMedGoogle Scholar
  138. Ward MJ, Fentem PH, Roderick Smith WH, Davies D (1981) Ipratropium bromide in acute asthma. Br Med J 282: 590–600Google Scholar
  139. Warren JB, Keynes RJ, Brown MJ, Jenner DA, McNicol MW (1982) Blunted sympathoadrenal response to exercise in asthmatic subjects. Br J Dis Chest 76: 147–150PubMedGoogle Scholar
  140. Warren JB, Dalton N, Turner C, Clark TJH (1984) Protective effect of circulating epinephrine within the physiological range on the airway response to inhaled histamine in non-asthmatic subjects. J Allergy Clin Immunol 74: 683–686PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • P. J. Barnes

There are no affiliations available

Personalised recommendations